Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Vomiting and KRAS[original query] |
---|
[Effect of KRAS mutation on efficacy of Cetuximab combined with chemotherapy in advanced colorectal cancer patients]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2009 Nov 12 (6): 594-7. Pu Xing-xiang, Deng Yan-hong, Xu Fei, Xiao Jian, Guo Hong-qiang, Huang He, Tian Ying, He You-jian, Lin Tong- |
Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: the PaLiDo study, a phase II nonrandomized multicenter study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2013 Jan 23 (1): 73-80. Steffensen Karina Dahl, Waldstrøm Marianne, Pallisgård Niels, Lund Bente, Bergfeldt Kjell, Wihl Jessica, Keldsen Nina, Marth Christian, Vergote Ignace, Jakobsen Ande |
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. The Lancet. Oncology 2014 May 15 (6): 601-11. Primrose John, Falk Stephen, Finch-Jones Meg, Valle Juan, O'Reilly Derek, Siriwardena Ajith, Hornbuckle Joanne, Peterson Mark, Rees Myrddin, Iveson Tim, Hickish Tamas, Butler Rachel, Stanton Louise, Dixon Elizabeth, Little Louisa, Bowers Megan, Pugh Siân, Garden O James, Cunningham David, Maughan Tim, Bridgewater Jo |
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma. Clinical colorectal cancer 2016 Mar . Bowles Daniel W, Kochenderfer Mark, Cohn Allen, Sideris Lucas, Nguyen Nghia, Cline-Burkhardt Vivian, Schnadig Ian, Choi Minsig, Nabell Lisle, Chaudhry Arvind, Ruxer Robert, Ucar Antonio, Hausman Diana, Walker Luke, Spira Alexander, Jimeno Anton |
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor. British journal of cancer 2017 Feb . Bendell Johanna C, Javle Milind, Bekaii-Saab Tanios S, Finn Richard S, Wainberg Zev A, Laheru Daniel A, Weekes Colin D, Tan Benjamin R, Khan Gazala N, Zalupski Mark M, Infante Jeffrey R, Jones Suzanne, Papadopoulos Kyriakos P, Tolcher Anthony W, Chavira Renae E, Christy-Bittel Janna L, Barrett Emma, Patnaik Ami |
Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study. Cancer research and treatment 2017 1 49 (4): 1022-1032. Woo Sang Myung, Kim Min Kyeong, Joo Jungnam, Yoon Kyong-Ah, Park Boram, Park Sang-Jae, Han Sung-Sik, Lee Ju Hee, Hong Eun Kyung, Kim Yun-Hee, Moon Hae, Kong Sun-Young, Kim Tae Hyun, Lee Woo J |
Phosphatidylinositol 3-Kinase ?-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 2 36 (13): 1291-1299. Juric Dejan, Rodon Jordi, Tabernero Josep, Janku Filip, Burris Howard A, Schellens Jan H M, Middleton Mark R, Berlin Jordan, Schuler Martin, Gil-Martin Marta, Rugo Hope S, Seggewiss-Bernhardt Ruth, Huang Alan, Bootle Douglas, Demanse David, Blumenstein Lars, Coughlin Christina, Quadt Cornelia, Baselga Jo |
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer. The oncologist 2020 12 26 (4): 290-e545. van Brummelen Emilie M J, Huijberts Sanne, van Herpen Carla, Desar Ingrid, Opdam Frans, van Geel Robin, Marchetti Serena, Steeghs Neeltje, Monkhorst Kim, Thijssen Bas, Rosing Hilde, Huitema Alwin, Beijnen Jos, Bernards Rene, Schellens J |
Efficacy and toxicity of drugs targeting KRAS mutation in non-small cell lung cancer: a meta-analysis. Expert review of anticancer therapy 2023 11 . Wei Luo, Jing Zhu, Wenxue Zhang, Airu Yu, Wei Zhou, Ke |
DNA Marker in Stool Led to a Second High-Quality Colonoscopy Within Three Months and Removal of an Undetected High-Risk Polyp. Clinical laboratory 2024 1 70 (1): . Susanne Franck, Moritz Eidens, Jürgen Fuhrländer, Dagfinn Ogre |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: